Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 461Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Cohance Lifesciences

02 1Octavius Pharma Pvt. Ltd

03 2Altius Healthcare

04 2Apotex Inc

05 2Ascent Innovative Medicines

06 1Aspire Lifesciences Pvt Ltd

07 2ENDO OPERATIONS

08 2Kolmar Korea Co., Ltd.

09 2Laboratorio Eczane Pharma

10 1Loxim Industries

11 4Murli Krishna Pharma

12 2Orchid Pharma

13 4Pelcoat Formulations

14 2Smilax Laboratories Limited

15 2TWi Pharmaceuticals

16 11Takeda Pharmaceutical

17 2Viatris

18 4World Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets/Micro pellets for capsules

Dosage Strength : 17; 20; 22.5; 23%; %; %; %

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Delayed Release Pellet

Dosage Strength : 22.5%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Pellets

Dosage Strength : 17%W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

11

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

12

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT SOLUTAB

Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2016-01-26

Application Number : 208056

Regulatory Info : DISCN

Registration Country : USA

blank

13

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

14

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

15

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

16

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

17

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

18

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

19

ENDO OPERATIONS

Country
AACR Annual meeting
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2017-04-19

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank

20

ENDO OPERATIONS

Country
AACR Annual meeting
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
AACR Annual meeting
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-06-16

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank